Medtech IPOs hit the exchanges with mixed fortunes
This article was originally published in Clinica
Executive Summary
February heralded a flurry of medtech IPOs, with five companies from the sector listing on the Nasdaq. However, the majority of the companies that listed failed to raise the anticipated amount of funds from the flotation.